Charles River Laboratories continues commitment to oncology drug discovery
Team of oncology experts expand data in Tumor Model Compendium and present strong portfolio at industry conferences...
List view / Grid view
Team of oncology experts expand data in Tumor Model Compendium and present strong portfolio at industry conferences...
Charles River Laboratories International, Inc. (NYSE: CRL) announced that its team of neuroscience drug discovery experts will present 26 scientific posters, both independently and collaboratively with clients, at Neuroscience 2018, the 48th annual meeting of the Society for Neuroscience (SfN)...
Charles River Laboratories International, Inc. announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimisation of antibody discovery platforms...
Extension includes new project to phenotype Parkinson’s disease models and the continuation of LRRK2 research.
Addition of high-throughput technologies and expanded pharmacokinetic services enhances existing support for small molecule drug discovery.
The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies.
Signs collaboration agreement with AstraZeneca to offer state-of-the-art technology to clients.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
Capture compound mass spectrometry technology enables target identification...
Are selective, brain-penetrant inhibitors of LRRK2 an answer?
Charles River Laboratories International, Inc. announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at Neuroscience 2017, the 47th annual meeting of the Society for Neuroscience (SfN).
Partnership with InSphero provides additional 3D solutions...
At Charles River, we are passionate about fostering innovation as our commitment to ensure clients are provided with the most efficient path to market...
Peer-reviewed paper on how touchscreen testing is a translational tool to assess cognitive function in a mouse model of Alzheimer’s disease...
Peer-reviewed publication on new strategies to target misfolded protein aggregates at various steps of protein production and processing...